#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Acatholytic Variant of Squamous Carcinoma of the Breast. A Case Report and Review of Literature


Authors: K. Kajo 1,2;  K. Macháleková 3;  M. Kajo 1;  P. Žúbor 4
Authors‘ workplace: Ústav patologickej anatómie, JLF UK a UN, Martin 1;  BB BIOCYT, diagnostické centrum, s. r. o., Banská Bystrica 2;  Oddelenie patológie, Onkologický ústav svätej Alžbety, s. r. o., Bratislava 3;  Gynekologicko-pôrodnícka klinika, JLF UK a UN, Martin 4
Published in: Čes.-slov. Patol., 47, 2011, No. 4, p. 184-188
Category: Original Article

Overview

The acantholytic variant of squamous carcinoma (ASC) represents a rare type of metaplastic breast carcinoma with typical occurrence of pseudoglandular and pseudovascular structures, arising as a result of cohesion loss between the neoplastic cells. Up to the present, there have been only 10 cases of mammary ASC described in the English written literature.

The authors present a case of a 57-year-old woman with a large (6 x 7 cm) suspicious lump on ultrasonography in her right breast treated by mastectomy with an ipsilateral axillary lymph node dissection due to histologically verified ASC. Additional postoperative staging computer tomography revealed metastatic foci in the left lungs, thus calling for adjuvant chemotherapy for the patient. Six months after setting the diagnosis, the patient is alive with a partial therapeutic response.

In the differential diagnosis of ASC it is important to exclude angiosarcoma, phyllodes tumor and metastatic sarcomas to the breast. The useful tools for differentiation between the above-mentioned entities are extensive bioptic examination and detailed immunohistochemical staining, enabling the pathologist to exclude the endothelial lineage (using CD31 and CD34) and to verify the epithelial origin through the detection of cytokeratins (spectra of high-molecular weight cytokeratins). Furthermore, the ASC shows positive immunohistochemical staining for markers of the myoepithelial differentiation, e.g. cytokeratin 14, CD10 and p63, suggesting an immature cell population with basaloid features.

In conclusion, as ASC is an aggressive subtype of the breast carcinoma with a poor prognosis, the correct diagnosis set by the pathologist is of great importance on the therapeutic management in affected patients.

Keywords:
carcinoma of the breast – metaplastic carcinoma – squamous carcinoma – acantholytic carcinoma


Sources

1. Aulmann S, Schnabel PA, Helmchen B, et al. Immunohistochemical and cytogenetic characterization of acantholytic squamous cell carcinoma of the breast. Virchows Arch 2005; 446(3): 305–309.

2. Banerjee SS, Eyden BP, McWilliam LJ, Harris M. Pseudoangiosarcomatous carcinoma: a clinical study of seven cases. Histopathology 1992; 21(1): 13–23.

3. Lever WF. Adenoacanthoma of sweat glands: carcinoma of sweat glands with glandular and epidermal elements: report of four cases. Arch Dermatol Syphilol 1947; 56(2): 157–171.

4. Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008; 9(8): 628–638.

5. Smoller BR. Squamous cell carcinoma: from precursor lesions to high-risk variants. Mod Pathol 2006; 19 Suppl 2: S88–92.

6. Cunha IW, Guimaraes GC, Soares F, et al. Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma: a clinicopathologic and outcome study of 7 patients. Am J Surg Pathol 2009; 33(9): 551–555.

7. Horie Y, Kato M. Pseudovascular squamous cell carcinoma of the uterine cervix: A lesion that may simulate an angiosarcoma. Patol Int 1999; 49(2): 170–174.

8. Jukič Z, Ledinsky I, Ulamec M, Ledinsky M, Krušlin B, Tomas D. Primary acantholytic squamous cell carcinoma of the cecum: a case report. Diagn Pathol 2011; 6(1): 5.

9. Kuraoka K, Takehara K, Oshita S, Saito A, Taniyama K. Acantolythic squamous cell carcinoma of the uterine cervix. Pathol Int 2010; 60(3): 245–246.

10. Papadopoulou E, Tosios KI, Nikitakis N, Papadogeorgakis N, Sklavounou-Andrikopoulou A. Acantholytic squamous cell carcinoma of the gingiva: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109(6): 67–71.

11. Zámečník M, Mukenšnabl P, Chlumská A. Pseudoglandular (adenoid, acantholytic) squamous cell carcinoma of the penis. A case report. Cesk Patol 2011; 47(1): 15–18.

12. Eusebi V, Lamovec J, Cattani MG, Fedeli F, Millis RR. Acantholytic variant of squamous-cell carcinoma of the breast. Am J Surg Pathol 1986; 10(12): 855–861.

13. Lee TH, Kim YB, Lee K, Yim H. Acantholytic variant of squamous cell carcinoma of the breast. Basic Appl Pathol 2010; 3: 34–37.

14. Parramore B, Hanly M, Yeh KA, McNeely T. Acantholytic variant of squamous cell carcinoma of the breast: a case report. Am Surg 1999; 65(5): 467–469.

15. Ellis IO, Sastre-Garau X, Bussolati G, et al. Invasive breast carcinoma. In: Tavassoli FA, Deville P, eds. World Health Organization of Tumours Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, IARC Press; 2003: 13–59.

16. Handschuh G, Candidus S, Luber B, et al. Tumor-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 1999; 18(30): 4301–4312.

17. Sarrió D, Rodriguez-Pinilla SM, Hardisson D, et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68(4): 989–997.

18. Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilles CB, Huntsman DG. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol 2007; 20(1): 84–89.

19. Lim KH, Oh DY, Chie EK, et al. Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity. Jpn J Clin Oncol 2010; 40(2): 112–118.

20. Reis-Filho JS, Milanezi F, Steele D, et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006; 49(1): 10–21.

21. Kinkor Z, Boudová L, Ryska A, Kajo K, Svec A. Matrix-producing breast carcinoma with myoepithelial differenntiation – description of 11 cases and review of literature aimed at histogenesis and differential diagnosis. Ceska Gynekol 2004; 69(3): 229–236.

22. Leibl S, Gogg-Kammerer M, Sommersacher A, Denk H, Moinfar F. Metaplastic breast carcinomas: are they of myoepithelial differentiation? Immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol 2005; 29(3): 347–53.

23. Rakha AE, Putti TC, Abd El-Rehim DM, et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differential differentiation. J Pathol 2006; 208: 495–506.

24. Gilbert JA, Goetz MP, Reynolds CA, et al. Molecular analysis of metaplastic breast carcinoma. Mol Cancer Ther 2008; 7(4): 944–951.

25. Wang H, Guan B, Shi Q, et al. May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis. Med Oncol 2011; 28(1): 42–50.

26. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4(12): 988–1004.

27. Perou CM. Molecular stratification of triple-negative breast cancers. The Oncologist 2010; 15(Suppl 5): 39–48.

28. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 2009; 69(10): 4116–4124.

29. Funai K, Yokose T, Ishii G, et al. Clinicopathologic characteristics of periheral squamous cell carcinoma of the lung. Am J Surg Pathol 2003; 27(9): 978–984.

30. Hsu W, Shen-Chen SM, Wang JL, Huang CC, Ko SF. Squamous cell lung carcinoma metastatic to the breast. Anticancer Res 2008; 28(2B): 1299–1231.

31. Rigby JE, Morris JA, Lavelle J, Stewart, M, Gatrell AC. Can physical trauma cause breast cancer? Eur J Cancer Prev 2002; 11(3): 307–311.

32. Stuelten CH, Barbul A, Busch JI, et al. Acute wounds accelerate tumorigenesis by a T cell- dependent mechanism. Cancer Res 2008; 68(18): 7278–7282.

33. Troester MA, Lee MH, Carter M, et al. Activation of host wound responses in breast cancer microenviroment. Clin Cancer Res 2009; 15(22): 7020–7028.

Labels
Anatomical pathology Forensic medical examiner Toxicology
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#